Tag: defense
COVID-19 fighter remdesivir racks up $873M as Gilead plays defense on...
Gilead Sciences started charging for remdesivir in July. Given its status then as the only drug authorized for COVID-19 in the U.S., industry watchers...
Left out of Warp Speed, Novavax scores $60M defense contract for...
Novavax wasn’t included in the U.S. government’s group of COVID-19 vaccine finalists for Operation Warp Speed, but only days after news of those picks broke,...
